Commentaries on Articles

• ADJUVANT RADIATION THERAPY FOR PANCREATIC CANCER.
• Nab – Paclitaxel has enhancing effects when used in combination with Gemcitabine for PDAC
  Commentary by: Dr. Kunal Suradkar
• Neoadjuvant  therapy for pancreatic cancer Dr Adarsh Chaudhary Department of G.I.Surgery, G.I.Oncology & Bariatric Surgery Medanta Medicity Hospital,Gurgaon  122001. India.
• Verma A, Arya S. COMMENTARY ON - Wen-Yi Zhao et al. Computed tomography in diagnosing vascular invasion in pancreatic and periampullary cancers: a systematic review and meta-analysis. Hepatobiliary Pancreat Dis Int 2009,8 (5); 457-464
  Commentary by: Dr. Ashish Verma , Department of Radiodiagnosis, Tata Memorial center, Mumbai
• EUS-guided celiac plexus neurolysis for pain due to chronic pancreatitis or pancreatic cancer pain: A meta-analysis and systematic review
  Commentary by: P N Jain, Professor
• Phase II Study of Bevacizumab With Concurrent Capecitabine and Radiation Followed by Maintenance Gemcitabine and Bevacizumab for Locally Advanced Pancreatic Cancer: Radiation Therapy Oncology Group RTOG 0411
  Commentary by: Dr. Pragya Shukla
• French study (SFRO-FFCD 9704), conducted between 1998-2003 and published in the Annals of Oncology in August 2009 Commentary by: Dr. Kaustav Talapatra
• A ray of hope for patients with advanced small bowel and ampullary adenocarcinomas
  Commentary by: Dr. Nirmal Raut and Dr. Sudeep Gupta
• Agarwal B, Correa AM, Ho L. Survival in pancreatic carcinoma based on tumor size. Pancreas. 2008 Jan; 36(1):e15-20
  Commentary by: Dr. Shailesh V. Shrikhande
• David Douglas.Tyrosine Kinase Inhibitor Promising in Pancreatic Cancer. Cancer 2007;110:1457-1468.
  Commentary by: Dr. Shailesh V. Shrikhande
• Artinyan A, Hellan M, Mojica-Manosa P. Improved Survival with Adjuvant External-Beam Radiation Therapy in Lymph Node-negative Pancreatic Cancer- A United States Population-Based Assessment. Cancer 2008; 112: 34-42.
  Commentary by: Dr. Umesh Mahantshetty